PRESCRIBING · PART D · 2024
Total Rx claims
451
Beneficiaries
—
Total drug cost
$118K
Distinct drugs
2
Brand share
100.0%
Top prescribed drugs
Buprenorphine Hcl/Naloxone Hcl317 claims
Buprenorphine Hcl/Naloxone Hcl74 claims
Naltrexone Microspheres41 claims
Buprenorphine Hcl/Naloxone Hcl19 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$55
Payment records
3
By payment type
Food and Beverage$55
Top paying entities
Food and Beverage$55
REFERRAL NETWORK
Where Stefanie Costello's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Quest Diagnostics Massachusetts Llc Clinical Laboratory · Marlborough, MA | 48 | 119 |
| CROFOOT, CATHERINE | 32 | 60 |
| Laureen Berkowitz Physician Assistant · Providence, RI | 26 | 41 |
| SOUTHCOAST HOSPITALS GROUP, INC | 16 | 25 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE